ArticleCancer2019

Targeting Burkitt lymphoma with a tumor cell-specific heptamethine carbocyanine-cisplatin conjugate.

Stefan Mrdenovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.